Atazanavir
- TRADE NAME: Reyataz (Bristol-Myers Squibb)
- INDICATIONS: HIV infection
- CLASS: Antiretroviral, Protease inhibitor, HIV
- HALF-LIFE: 7 hours
Abiraterone, Alfuzosin, Amiodarone, Antacids, Aripiprazole, Artemether/Lumefantrine, Atorvastatin, Avanafil, Bepridil, Bosentan, Buprenorphine, Cisapride, Clarithromycin, Colchicine, Crizotinib, Cyclosporine, Darifenacin, Dasatinib, Dexlansoprazole, Diltiazem, Dofetilide, Efavirenz, Ergot derivatives, Erlotinib, Estrogens, Etravirine, Everolimus, Famotidine, Felodipine, Fentanyl, Fesoterodine, Fluticasone, Garlic, Indinavir, Irinotecan, Itraconazole, Ixabepilone, Ketoconazole, Lapatinib, Lidocaine, Lopinavir, Lovastatin, Maraviroc, Marihuana, Midazolam, Mifepristone, Nevirapine, Nicardipine, Nifedipine, Omeprazole, Oral contraceptives, Paclitaxel, Pantoprazole, Pimozide, Posaconazole, Proton-pump inhibitors, Quetiapine, Quinidine, Quinine, Rabeprazole, Raltegravir, Ranolazine, Rifabutin, Rifampin, Rilpivirine, Ritonavir, Rivaroxaban, Romidepsin, Rosuvastatin, Salmeterol, Saquinavir, Sildenafil, Simvastatin, Sirolimus, Solifenacin, St John's Wort, Sunitinib, Tacrolimus, Tadalafil, Telaprevir, Telithromycin, Temsirolimus, Tenofovir, Ticagrelor, Tipranavir, Trazodone, Triazolam, Tricyclic antidepressants, Vardenafil, Vemurafenib, Verapamil, Voriconazole, Warfarin
PREGNANCY CATEGORY: B
Use in pediatric patients <6 years of age is under investigation.
Please login to see the rest of this drug profile
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life Threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric